Natalizumab and impedance of the homing of CD34+ hematopoietic progenitors.
Saure C, Warnke C, Zohren F, Schroeder T, Bruns I, Cadeddu RP, Weigelt C, Fischer U, Kobbe G, Hartung HP, Adams O, Kieseier BC, Haas R.
Saure C, et al.
Arch Neurol. 2011 Nov;68(11):1428-31. doi: 10.1001/archneurol.2011.238.
Arch Neurol. 2011.
PMID: 22084125